ID

28971

Description

Study part: Study Drug Administration Month 3. A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration.

Mots-clés

Versions (1)
  1. 18/02/2018 18/02/2018 -
Détendeur de droits

Roche

Téléchargé le

18 février 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Study Drug Administration Month 3 rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2598g

Anglais

Study Drug Administration Month 3

1 Formulaires  
STUDY DRUG ADMINISTRATION (MONTH 3)
Description

STUDY DRUG ADMINISTRATION (MONTH 3)

Alias
UMLS CUI-1
C3469597
Subject Number:
Description

Subject Number

Type de données

text

Alias
UMLS CUI [1]
C2348585
Subject Initials:
Description

Subject Initials

Type de données

text

Alias
UMLS CUI [1,1]
C1997894
UMLS CUI [1,2]
C2986440
Visit Date:
Description

Visit Date

Type de données

date

Alias
UMLS CUI [1]
C1320303
Was treatment (rhuFab V2 or sham procedure) administered?
Description

Therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0087111
If Yes, Record kit # administered:
Description

identification number

Type de données

text

Alias
UMLS CUI [1]
C1300638
Date Administered:
Description

Date Administered

Type de données

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C1533734
Time Administered:
Description

Time Administered

Type de données

time

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C1533734
Was lidocaine injection administered?
Description

Drug Administration lidocaine

Type de données

boolean

Alias
UMLS CUI [1,1]
C3469597
UMLS CUI [1,2]
C0023660
Were preoperative antimicrobials given?
Description

preoperative antimicrobials

Type de données

boolean

Alias
UMLS CUI [1]
C2114165
If No, Was treatment held due to any of the Study Drug Dose-Holding Criteria?
Description

drug dosage

Type de données

boolean

Alias
UMLS CUI [1]
C0870450
If Yes, check the corresponding event(s) for holding treatment:
Description

Therapy

Type de données

text

Alias
UMLS CUI [1]
C0087111
Retour au début de la page

Similar models

Study Drug Administration Month 3

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
STUDY DRUG ADMINISTRATION (MONTH 3)
C3469597 (UMLS CUI-1)
Subject Number
Item
Subject Number:
text
C2348585 (UMLS CUI [1])
Subject Initials
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
Visit Date
Item
Visit Date:
date
C1320303 (UMLS CUI [1])
Therapy
Item
Was treatment (rhuFab V2 or sham procedure) administered?
boolean
C0087111 (UMLS CUI [1])
identification number
Item
If Yes, Record kit # administered:
text
C1300638 (UMLS CUI [1])
Date Administered
Item
Date Administered:
date
C0011008 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
Time Administered
Item
Time Administered:
time
C0040223 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
Drug Administration lidocaine
Item
Was lidocaine injection administered?
boolean
C3469597 (UMLS CUI [1,1])
C0023660 (UMLS CUI [1,2])
preoperative antimicrobials
Item
Were preoperative antimicrobials given?
boolean
C2114165 (UMLS CUI [1])
drug dosage
Item
If No, Was treatment held due to any of the Study Drug Dose-Holding Criteria?
boolean
C0870450 (UMLS CUI [1])
Item
If Yes, check the corresponding event(s) for holding treatment:
text
C0087111 (UMLS CUI [1])
Therapy
Code List
If Yes, check the corresponding event(s) for holding treatment:
CL Item
Intraocular inflammation (Intraocular inflammation)
C0497211 (UMLS CUI-1)
(Comment:en)
CL Item
Visual acuity loss (Visual acuity loss)
C1836949 (UMLS CUI-1)
(Comment:en)
CL Item
Intraocular pressure (IOP) (Intraocular pressure (IOP))
C0578862 (UMLS CUI-1)
(Comment:en)
CL Item
Vitreous hemorrhage (Vitreous hemorrhage)
C0042909 (UMLS CUI-1)
(Comment:en)
CL Item
Sensory rhegmatogenous retinal break or detachment (Sensory rhegmatogenous retinal break or detachment)
C0035305 (UMLS CUI-1)
(Comment:en)
CL Item
Subfoveal hemorrhage (Subfoveal hemorrhage)
C0442185 (UMLS CUI-1)
C0019080 (UMLS CUI-2)
(Comment:en)
CL Item
Local or systemic infection (Local or systemic infection)
C0009450 (UMLS CUI-1)
(Comment:en)
CL Item
Intraocular surgery (Intraocular surgery)
C0038894 (UMLS CUI-1)
C3282905 (UMLS CUI-2)
(Comment:en)
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial